Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Cancer Medicine
|
August 18, 2021
Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trial
Caitlin C Murphy, Hannah M Fullington, David E Gerber, et al.
Nature Communications
|
March 23, 2024
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial
Emily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, et al.
The Oncologist
|
February 15, 2026
A prospective external validation of the GRade, Age, Nodes and Tumor (GRANT) score in the ECOG-ACRIN EA8143 PROSPER trial
Sebastiano Buti, Se-Eun Kim, Michele Maffezzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2011
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines
Kangshen Yao, Seiichiro Shida, Muthu Selvakumaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2021
Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805)
Wenxin Xu, Mäneka Puligandla, Brian Halbert, et al.
Cancer
|
October 30, 2003
Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network
Naomi B Haas, Bruce J Giantonio, Samuel Litwin, et al.
The Oncologist
|
April 12, 2026
OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care
Henry K Litt, Amelia Wodzinski, Pearl Subramanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study
Naomi B Haas, Mitchell Smith, Nancy Lewis, et al.
The Journal of Urology
|
July 22, 2017
Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial
Benjamin T Ristau, Judi Manola, Naomi B Haas, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Cancer Medicine
|
August 18, 2021
Adherence to oral therapies among patients with renal cell carcinoma: Post hoc analysis of the ECOG-ACRIN E2805 trial
Caitlin C Murphy, Hannah M Fullington, David E Gerber, et al.
Nature Communications
|
March 23, 2024
Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial
Emily K Ninmer, Hong Zhu, Kimberly A Chianese-Bullock, et al.
The Oncologist
|
February 15, 2026
A prospective external validation of the GRade, Age, Nodes and Tumor (GRANT) score in the ECOG-ACRIN EA8143 PROSPER trial
Sebastiano Buti, Se-Eun Kim, Michele Maffezzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2011
Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine
Craig L Slingluff, Gina R Petroni, Kimberly A Chianese-Bullock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines
Kangshen Yao, Seiichiro Shida, Muthu Selvakumaran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2021
Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805)
Wenxin Xu, Mäneka Puligandla, Brian Halbert, et al.
Cancer
|
October 30, 2003
Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network
Naomi B Haas, Bruce J Giantonio, Samuel Litwin, et al.
The Oncologist
|
April 12, 2026
OncoEducate: A Pilot Study of Generative AI to Enhance Patient-Clinician Communication in Genitourinary Cancer Care
Henry K Litt, Amelia Wodzinski, Pearl Subramanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study
Naomi B Haas, Mitchell Smith, Nancy Lewis, et al.
The Journal of Urology
|
July 22, 2017
Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial
Benjamin T Ristau, Judi Manola, Naomi B Haas, et al.
Page
of 11